Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

Fosun Pharma to Spend $73.5 Million on Global Technology Incubator

publication date: Jul 11, 2017
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
Fosun Pharma will invest $73.5 million over nine years in an innovative technology incubator. The incubator will search worldwide for innovative projects, which Fosun said will help meet its stategic innovative and global goals. Professor Tian Xu, deputy head of Genetics at Yale University and Chief Science Advisor to Fosun, will serve as the chairman of the incubator’s academic committee. The Fosun incubator will seek innovative technologies in pharmaceuticals, regenerative medicine and artificial intelligence. More details....

Stock Symbols: (SHA: 600196; HK: 2196)

Share this with colleagues:  


This article is available for purchase - please click here for details.


Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...

Login